Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CRB059
MIFTS: 37

Cerebellar Degeneration

Categories: Metabolic diseases, Neuronal diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Cerebellar Degeneration

About this section

MalaCards integrated aliases for Cerebellar Degeneration:

Name: Cerebellar Degeneration 52 53 54 71

Classifications:

MalaCards categories:
Global: Rare diseases Metabolic diseases
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)


External Ids:

UMLS 71 C0262404
Sources

Summaries for Cerebellar Degeneration

About this section
NINDS : 53 Cerebellar degeneration is a process in which neurons (nerve cells) in the cerebellum - the area of the brain that controls coordination and balance - deteriorate and die. Diseases that cause cerebellar degeneration can also involve other areas of the central nervous system, including the spinal cord, medulla oblongata, cerebral cortex, and brain stem. Cerebellar degeneration may be the result of inherited genetic mutations that alter the normal production of specific proteins that are necessary for the survival of neurons.  In some cases the disease is aqauired (is non-hereditary or non-genetic). The most characteristic symptom of cerebellar degeneration is a wide-based, unsteady, lurching walk, often accompanied by a back and forth tremor in the trunk of the body. Other symptoms may include slow, unsteady and jerky movement of the arms or legs, slowed and slurred speech, and nystagmus -- rapid, small movements of the eyes. Associated diseases: Diseases that are specific to the brain, as well as diseases that occur in other parts of the body, can cause neurons to die in the cerebellum. Neurological diseases that feature cerebellar degeneration include: ischemic or hemorrhagic stroke, when there is lack of blood flow or oxygen to the cerebellum cerebellar cortical atrophy, multisystem atrophy, and olivopontocerebellar degeneration, progressive degenerative disorders in which cerebellar degeneration is a key feature Friedreich’s ataxia, and other spinocerebellar ataxias, which are caused by inherited genetic mutations that result in ongoing loss of neurons in the cerebellum, brain stem, and spinal cord transmissible spongiform encephalopathies (such as Creutzfeldt-Jakob disease) in which abnormal proteins cause inflammation in the brain, including the cerebellum multiple sclerosis, in which damage to the insulating membrane (myelin) that wraps around and protects nerve cells can involve the cerebellum Acquired diseases that can cause cerebellar degeneration include: chronic alcohol abuse that leads to temporary or permanent cerebellar damage paraneoplastic disorders, in which a malignancy (cancer) in other parts of the body produces substances that cause immune system cells to attack neurons in the cerebellum

MalaCards based summary : Cerebellar Degeneration is related to paraneoplastic cerebellar degeneration and cerebellar disease. An important gene associated with Cerebellar Degeneration is CDR2 (Cerebellar Degeneration Related Protein 2), and among its related pathways/superpathways are ATM Pathway and BRCA1 Pathway. The drugs Varenicline and Antibodies have been mentioned in the context of this disorder. Affiliated tissues include cerebellum, brain and cortex, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor)

NIH Rare Diseases : 52 Cerebellar degeneration refers to the deterioration of neurons (nerve cells ) in the cerebellum (the area of the brain that controls muscle coordination and balance). Conditions that cause cerebellar degeneration may also affect other areas of the central nervous system , such as the spinal cord, the cerebral cortex (the thin layer of cells covering the brain), and the brain stem. Signs and symptoms of cerebellar degeneration may include a wide-based, uncoordinated walk; a back and forth tremor in the trunk of the body; uncoordinated movements of the arms and legs; slow and slurred speech; and nystagmus . Cerebellar degeneration can be caused by a variety of factors including inherited gene changes (mutations ), chronic alcohol abuse, and paraneoplastic disorders . Treatment for cerebellar degeneration varies depending on the underlying cause.

Wikipedia : 74 Cerebellar degeneration is a condition in which cerebellar cells, otherwise known as neurons, become... more...

Sources

Related Diseases for Cerebellar Degeneration

About this section

Diseases in the Cerebellar Degeneration family:

Primary Cerebellar Degeneration Subacute Cerebellar Degeneration

Diseases related to Cerebellar Degeneration via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 319)
# Related Disease Score Top Affiliating Genes
1 paraneoplastic cerebellar degeneration 34.2 CDR2 CDR1
2 cerebellar disease 30.2 CACNA1A ATM
3 ataxia-telangiectasia 28.7 MRE11 ATM AP2B1
4 subacute cerebellar degeneration 12.7
5 ichthyosis, hepatosplenomegaly, and cerebellar degeneration 12.6
6 primary cerebellar degeneration 12.4
7 paraneoplastic neurologic disorders 11.9
8 spinocerebellar ataxia 2 11.7
9 paraneoplastic syndromes 11.5
10 spinocerebellar degeneration 11.4
11 menkes disease 11.4
12 ataxia-telangiectasia-like disorder 1 11.4
13 familial hemiplegic migraine 11.4
14 infantile cerebellar-retinal degeneration 11.2
15 migraine, familial hemiplegic, 1 11.1
16 ataxias and cerebellar or spinocerebellar degeneration 11.1
17 spinocerebellar atrophy 11.1
18 ataxia and polyneuropathy, adult-onset 10.8
19 aceruloplasminemia 10.7
20 pathologic nystagmus 10.5
21 ovarian cancer 10.5
22 lambert-eaton myasthenic syndrome 10.4
23 tremor 10.4
24 small cell carcinoma 10.4
25 adenocarcinoma 10.4
26 breast cancer 10.3
27 small cell cancer of the lung 10.3
28 autosomal dominant cerebellar ataxia 10.2
29 ovary adenocarcinoma 10.2
30 encephalitis 10.2
31 limbic encephalitis 10.2
32 alcohol dependence 10.2
33 lymphoma, hodgkin, classic 10.2
34 neuropathy 10.2
35 lymphoma 10.2
36 olivopontocerebellar atrophy 10.2
37 lambert syndrome 10.1
38 dysphagia 10.1
39 acute diffuse nephritis 10.1 CDR2 CDR1
40 retinitis pigmentosa 47 10.1 CDR2 CDR1
41 autoimmune disease 10.1
42 machado-joseph disease 10.1
43 paraplegia 10.1
44 retinitis pigmentosa 57 10.1 CDR2 CDR1
45 anosognosia 10.1 CDR2 CDR1
46 denture stomatitis 10.1 CDR2 CDR1
47 multiple system atrophy 1 10.1
48 endometrial cancer 10.1
49 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
50 sensory peripheral neuropathy 10.1

Graphical network of the top 20 diseases related to Cerebellar Degeneration:



Diseases related to Cerebellar Degeneration
Sources

Symptoms & Phenotypes for Cerebellar Degeneration

About this section

GenomeRNAi Phenotypes related to Cerebellar Degeneration according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.53 ATM CDR2 CDR2L MRE11
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.53 ATM CDR2 CDR2L MRE11
Sources

Drugs & Therapeutics for Cerebellar Degeneration

About this section

Drugs for Cerebellar Degeneration (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Varenicline Approved, Investigational Phase 2 249296-44-4 5310966
2 Antibodies Phase 2
3 Immunoglobulins Phase 2
4 Rho(D) Immune Globulin Phase 2
5 Immunologic Factors Phase 2
6 Immunoglobulins, Intravenous Phase 2
7 gamma-Globulins Phase 2
8 Neurotransmitter Agents Phase 2
9 Nicotinic Agonists Phase 2
10 Cholinergic Agents Phase 2
11
Tacrolimus Approved, Investigational 104987-11-3 445643 439492 6473866
12
Prednisone Approved, Vet_approved 53-03-2 5865
13 Omega 3 Fatty Acid
14 Immunosuppressive Agents
15 Calcineurin Inhibitors

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 The Efficacy of High-Dose Intravenous Immunoglobulin Therapy In Patients With Cerebellar Degeneration: A Double Blind, Placebo Controlled Trial Completed NCT00034242 Phase 2 high-dose intravenous immunoglobulin (IVIG)
2 A Pilot, Randomized, Double-blind, Placebo-controlled Phase I Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3 Completed NCT00992771 Phase 2 varenicline;placebo
3 Early Onset Immunotherapy by Intravenous Immunoglobulin in Well-characterized Onconeural-antibody-positive Paraneoplastic Neurological Syndromes Completed NCT02343211 Phase 2 Immunoglobulin
4 Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus Withdrawn NCT00603135 Phase 2 first-line i/v-levetiracetam
5 Translating Molecular Pathology Into a Therapeutic Strategy in SCA38, a Newly Identified Form of Spinocerebellar Ataxia Completed NCT03109626
6 Immunotherapy of the Paraneoplastic Syndromes Completed NCT00378326 Tacrolimus
7 Disorders of Emotional Communication in Patient With Cerebellar Dysfunction Completed NCT02106819

Search NIH Clinical Center for Cerebellar Degeneration

Sources

Genetic Tests for Cerebellar Degeneration

About this section
Sources

Anatomical Context for Cerebellar Degeneration

About this section

MalaCards organs/tissues related to Cerebellar Degeneration:

40
Cerebellum, Brain, Cortex, Spinal Cord, Lung, Breast, Eye
Sources

Publications for Cerebellar Degeneration

About this section

Articles related to Cerebellar Degeneration:

(show top 50) (show all 1554)
# Title Authors PMID Year
1
Autopsy study of cerebellar degeneration in siblings with ataxia-telangiectasia-like disorder. 54 61
20087742 2010
2
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. 54 61
19581925 2009
3
Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration. 54 61
18053582 2008
4
Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells. 54 61
16696854 2006
5
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique. 54 61
16542365 2006
6
CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics. 54 61
15985579 2005
7
A cluster of familial Creutzfeldt-Jakob disease mutations recapitulate conserved residues in Doppel: a case of molecular mimicry? 54 61
12459456 2002
8
[Familial hemiplegic migraine]. 54 61
15775664 2001
9
Global analysis of ATM polymorphism reveals significant functional constraint. 54 61
11443540 2001
10
The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. 54 61
10465786 1999
11
Genetics of the SCA6 gene in a large family segregating an autosomal dominant "pure" cerebellar ataxia. 54 61
10051016 1999
12
Neuropathological study of cerebellar degeneration in prion disease. 54 61
19519645 1999
13
Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. 54 61
9770541 1998
14
[Physiopathology of calcium channels: identification of calcium channelopathies]. 54 61
9759359 1998
15
Heterozygous ATM mutations do not contribute to early onset of breast cancer. 54 61
9054948 1997
16
Ataxia-telangiectasia: founder effect among north African Jews. 54 61
8968760 1996
17
Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. 54 61
7671305 1995
18
CDR1as/miRNAs-related regulatory mechanisms in muscle development and diseases. 61
31904497 2020
19
Phase I randomized single-blinded controlled study investigating the potential benefit of aerobic exercise in degenerative cerebellar disease. 61
32037861 2020
20
Combined Cerebellar and Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy. 61
31970005 2020
21
Epidemiology of paraneoplastic neurological syndromes: a population-based study. 61
31552550 2020
22
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis. 61
31935372 2020
23
Selective Procedural Memory Impairment but Preserved Declarative Memory in Spinocerebellar Ataxia Type 3. 61
31912433 2020
24
CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis. 61
31917898 2020
25
Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association. 61
31161534 2019
26
The Classification of Autosomal Recessive Cerebellar Ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force. 61
31267374 2019
27
Functional Assessment In Vivo of the Mouse Homolog of the Human Ala-9-Ser NHE6 Variant. 61
31676550 2019
28
Cerebellar contribution to auditory feedback control of speech production: Evidence from patients with spinocerebellar ataxia. 61
31365181 2019
29
Non-small cell lung cancer associated with late-onset Lambert-Eaton myasthenic syndrome and paraneoplastic cerebellar degeneration. 61
31735997 2019
30
Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell Leukemia. 61
31743320 2019
31
Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approach. 61
31317229 2019
32
Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42. 61
31229688 2019
33
Characterization of Cerebellar Atrophy and Resting State Functional Connectivity Patterns in Sporadic Adult-Onset Ataxia of Unknown Etiology (SAOA). 61
31422550 2019
34
Short Review: Investigating ARSACS: models for understanding cerebellar degeneration. 61
30636067 2019
35
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature. 61
31463826 2019
36
Embryonic Cerebellar Graft Morphology Differs in Two Mouse Models of Cerebellar Degeneration. 61
31418135 2019
37
Cerebellar Hypermetabolism in a Case of Paraneoplastic Cerebellar Syndrome With the Primary Lymphoepithelial Carcinoma in Tonsil. 61
31162262 2019
38
Biallelic variants in AGTPBP1, involved in tubulin deglutamylation, are associated with cerebellar degeneration and motor neuropathy. 61
30976113 2019
39
Mass spectrometry imaging reveals ganglioside and ceramide localization patterns during cerebellar degeneration in the Npc1-/- mouse model. 61
31254056 2019
40
Extensive cerebellar and thalamic degeneration in spinocerebellar ataxia type 10. 61
31445906 2019
41
Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. 61
31289815 2019
42
MyoD-induced circular RNA CDR1as promotes myogenic differentiation of skeletal muscle satellite cells. 61
31323434 2019
43
Internal model recalibration does not deteriorate with age while motor adaptation does. 61
31170534 2019
44
Rare case of paraneoplastic cerebellar degeneration secondary to high-grade serous carcinoma of tubo-ovarian origin. 61
31466977 2019
45
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration. 61
31148214 2019
46
GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome. 61
31236596 2019
47
Alterations in Cognition-Related Cerebello-Cerebral Networks in Multiple System Atrophy. 61
31069705 2019
48
Cognitive and Psychiatric Evaluation in SYNE1 Ataxia. 61
31049853 2019
49
Circular RNA circ_0001946 acts as a competing endogenous RNA to inhibit glioblastoma progression by modulating miR-671-5p and CDR1. 61
30663767 2019
50
[Paraneoplastic cerebellar degeneration and primary fallopian cancer]. 61
31239210 2019
Sources

Variations for Cerebellar Degeneration

About this section
Sources

Expression for Cerebellar Degeneration

About this section
Search GEO for disease gene expression data for Cerebellar Degeneration.
Sources

Pathways for Cerebellar Degeneration

About this section

Pathways related to Cerebellar Degeneration according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
ATM Pathway 63
Show member pathways
 11.34 MRE11 ATM
2
BRCA1 Pathway 63
Show member pathways
 11.29 MRE11 ATM
3
Regulation of Telomerase 1
11.14 MRE11 ATM
4
Integrated Cancer Pathway 1
10.92 MRE11 ATM
5
ATM Signaling Network in Development and Disease 1
10.82 MRE11 ATM
6
BARD1 signaling events 1
10.42 MRE11 ATM
7
DDX1 as a regulatory component of the Drosha microprocessor 1
Show member pathways
 9.83 MRE11 ATM
Sources

GO Terms for Cerebellar Degeneration

About this section

Cellular components related to Cerebellar Degeneration according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chromosome, telomeric region GO:0000781 8.62 MRE11 ATM

Biological processes related to Cerebellar Degeneration according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 double-strand break repair via homologous recombination GO:0000724 9.32 MRE11 ATM
2 double-strand break repair via nonhomologous end joining GO:0006303 9.26 MRE11 ATM
3 telomere maintenance GO:0000723 9.16 MRE11 ATM
4 reciprocal meiotic recombination GO:0007131 8.96 MRE11 ATM
5 DNA double-strand break processing GO:0000729 8.62 MRE11 ATM
Sources

Sources for Cerebellar Degeneration

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....